On August 3, 2020, the Board of Directors of Sarepta Therapeutics, Inc. designated Joseph Bratica, the Company’s Vice President, Corporate Controller, as the Company’s interim Principal Financial and Accounting Officer, effective immediately. Mr. Bratica, age 57, has served as the Company’s Vice President, Corporate Controller, since March 2017. Prior to joining the Company, Mr. Bratica served in various financial advisory roles at ARIAD Pharmaceuticals, Inc., including as Vice President, Controller, between 2005 to 2016.